Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06357871
What this trial is testing

Role of Renal Biopsy in the Suspicion of Nephrotoxicity of Immunotherapy (Checkpoint Inhibitors) in Solid Cancer

Who this might be right for
Chemotherapeutic Toxicity
Central Hospital, Nancy, France 100
Not applicableEnded earlyNCT03951012
What this trial is testing

Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy

Who this might be right for
Non Small Cell Lung Cancer
Muhammad Furqan 29
Not applicableActive Not RecruitingNCT04990726
What this trial is testing

Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more
M.D. Anderson Cancer Center 126
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Early research (Phase 1)Study completedNCT02406183
What this trial is testing

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

Who this might be right for
MelanomaEffects of ImmunotherapyAdverse Effect of Radiation Therapy
Radiotherapie 13
Early research (Phase 1)Ended earlyNCT00923390
What this trial is testing

Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor

Who this might be right for
Renal CancerKidney Cancer
National Cancer Institute (NCI) 5
Early research (Phase 1)UnknownNCT06095674
What this trial is testing

ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study

Who this might be right for
Cervical Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableEnrolling By InvitationNCT06605833
What this trial is testing

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Who this might be right for
Melanoma Stage III or IV
Royal Marsden NHS Foundation Trust 60
Not applicableLooking for participantsNCT05885048
What this trial is testing

Impact of Gonadotoxic Therapies on Fertility

Who this might be right for
CancerFertility IssuesFertility Preservation+3 more
Michael von Wolff 7,000
Not applicableStudy completedNCT04954885
What this trial is testing

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more
Ohio State University Comprehensive Cancer Center 2
Not applicableActive Not RecruitingNCT06277388
What this trial is testing

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

Who this might be right for
Non-small Cell Lung CancerCardiac Toxicity
Sun Yat-sen University 231
Early research (Phase 1)Temporarily pausedNCT02988258
What this trial is testing

Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT

Who this might be right for
Haematological MalignanciesCMV Infection
University College, London 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Not applicableStudy completedNCT07337486
What this trial is testing

"Evaluation of a Non-Pharmacological Skin Care Intervention for the Prevention and Treatment of Skin Toxicities Caused by Immunotherapy in Cancer Patients"

Who this might be right for
Skin Toxicity in Patients on Checkpoint Inhibitors
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 130
Not applicableUnknownNCT04965129
What this trial is testing

Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet

Who this might be right for
Lung Cancer
Universidade Federal do Rio de Janeiro 50
Early research (Phase 1)Ended earlyNCT03330834
What this trial is testing

CAR-T Cell Immunotherapy for Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
Sun Yat-sen University 1
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT00740415
What this trial is testing

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 39
Early research (Phase 1)Active Not RecruitingNCT04163289
What this trial is testing

Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation

Who this might be right for
Renal Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Not applicableLooking for participantsNCT05878964
What this trial is testing

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Who this might be right for
Lung CancerBreast CancerKidney Cancer+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Next Page